PPAR active compounds

Details PPAR active compounds PPAR active compounds

2008-03-05

2011-11-08

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S452000

Reexamination Certificate

active

08053463

ABSTRACT:
Compounds are described that are active on at least one of PPARα, PPARδ, and PPARγ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARγ, wherein the compounds have the formula:wherein:X2and X3are independently CH or N; andone of X1and X4is N or CR4and the other of X1and X4is N or CH.

REFERENCES:
patent: 3489767 (1970-01-01), Yamamoto et al.
patent: 3511841 (1970-05-01), Archer et al.
patent: 3557142 (1971-01-01), Bell et al.
patent: 4150949 (1979-04-01), Smith
patent: 4564610 (1986-01-01), Rahtz et al.
patent: 4568649 (1986-02-01), Bertoglio-Matte
patent: 4626513 (1986-12-01), Burton et al.
patent: 5075313 (1991-12-01), Yu et al.
patent: 5466689 (1995-11-01), Yamamoto et al.
patent: 5747276 (1998-05-01), Hoch et al.
patent: 5760040 (1998-06-01), Yoshida et al.
patent: 5763198 (1998-06-01), Hirth et al.
patent: 5840485 (1998-11-01), Lebl et al.
patent: 5877007 (1999-03-01), Housey
patent: 6090912 (2000-07-01), Lebl et al.
patent: 6178384 (2001-01-01), Kolossvary
patent: 6243980 (2001-06-01), Bronstein et al.
patent: 6288234 (2001-09-01), Griffin
patent: 6294330 (2001-09-01), Michnick et al.
patent: 6329389 (2001-12-01), Suzuki et al.
patent: 6331537 (2001-12-01), Hamilton et al.
patent: 6337344 (2002-01-01), Defossa et al.
patent: 6395768 (2002-05-01), Pappolla et al.
patent: 6608059 (2003-08-01), Daines et al.
patent: 6635655 (2003-10-01), Jayyosi et al.
patent: 6869975 (2005-03-01), Abe et al.
patent: 7202266 (2007-04-01), Arnold et al.
patent: 7259175 (2007-08-01), Conner et al.
patent: 7348338 (2008-03-01), Arnold et al.
patent: 7476746 (2009-01-01), Artis et al.
patent: 7572806 (2009-08-01), Arnold et al.
patent: 2003/0216452 (2003-11-01), Sredy et al.
patent: 2004/0006071 (2004-01-01), Simoneau et al.
patent: 2004/0077595 (2004-04-01), Cheng et al.
patent: 2005/0004115 (2005-01-01), Sharma et al.
patent: 2006/0111426 (2006-05-01), Bonnert et al.
patent: 2007/0072904 (2007-03-01), Lin et al.
patent: 2007/0149603 (2007-06-01), Arnold et al.
patent: 2008/0045581 (2008-02-01), Arnold et al.
patent: 0 154 734 (1990-08-01), None
patent: 0 610 793 (1994-08-01), None
patent: 0 620 214 (1994-10-01), None
patent: 1 219 595 (2002-07-01), None
patent: 1 267 111 (2002-12-01), None
patent: 1 285 908 (2003-02-01), None
patent: 1 661 879 (2006-05-01), None
patent: 1 128 607 (1968-09-01), None
patent: 1 241 637 (1971-08-01), None
patent: 2 407 318 (2005-04-01), None
patent: 2240793 (2004-11-01), None
patent: WO-91/13060 (1991-09-01), None
patent: WO-93/02050 (1993-02-01), None
patent: WO-96/04906 (1996-02-01), None
patent: WO-99/58503 (1999-11-01), None
patent: WO-00/64876 (2000-11-01), None
patent: WO-01/38305 (2001-05-01), None
patent: WO-02/30863 (2002-04-01), None
patent: WO 02/062774 (2002-08-01), None
patent: WO-03/064387 (2003-08-01), None
patent: WO-03/105847 (2003-12-01), None
patent: WO 2004/005253 (2004-01-01), None
patent: WO-2004/007439 (2004-01-01), None
patent: WO-2004/007451 (2004-01-01), None
patent: WO-2004/020409 (2004-03-01), None
patent: WO-2004/056740 (2004-07-01), None
patent: WO-2004/058164 (2004-07-01), None
patent: WO-2004/063190 (2004-07-01), None
patent: WO-2004/092131 (2004-10-01), None
patent: WO-2004/094372 (2004-11-01), None
patent: WO 2005/009958 (2005-02-01), None
patent: WO-2005/037763 (2005-04-01), None
patent: WO-2005/040112 (2005-05-01), None
patent: WO-2005/040114 (2005-05-01), None
patent: WO-2005/044787 (2005-05-01), None
patent: WO-2005/054176 (2005-06-01), None
patent: WO-2005/056522 (2005-06-01), None
patent: WO-2005/060958 (2005-07-01), None
patent: WO-2005/092131 (2005-10-01), None
patent: WO-2005/121141 (2005-12-01), None
patent: WO 2007/030559 (2007-03-01), None
patent: WO 2007/030574 (2007-03-01), None
Berger, J. and Wagner, J.A., Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors,Diabetes Tech. &Ther., 4:163-174 (2002).
Breidert et al., Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease,Journal of Neurochemistry, 82:615 (2002).
Combs et al., Inflammatory Mechanisms in Alzheimer's Disease: Inhibition of β-Amyloid-Stimulated Proinflammatory Responses and Neurotoxicity by PPARγ Agonists,Journal of Neuroscience20(2):558 (2000).
Cronet et al., Structure of the PPARα and —γ Ligand Binding Domain in Complex with AZ 242; Ligand Selectivity and Agonist Activation in the PPAR Family,Structure(Camb.), 9:699-706 (2001).
Fajas et al., The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene,J. Biol. Chem., 272:18779-18789 (1997).
Feinstein, D.L., Contrasting the neuroprotective and gliotoxic effects of PPARγ agonists,Drug Discovery Today: Therapeutic Strategies, 1(1):29-34 (2004).
Fu et al., Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α,Nature, 425:9093 (2003).
Kota et al., An overview on biological mechanisms of PPARδPharmacological Research, 51:85-94 (2005).
Liebowitz et al., Activation of PPARδ alters lipid metabolism in db/db mice,FEBS Lett., 473:333-336 (2000).
Lohray et al., (−)3-[4-[2-(Phenoxazin-10-y1)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF 2725]: A Dual PPAR Agonist with Potent Antihyperglycemic and Lipid Modulating Activity,J. Med. Chem., 44:2675-2678 (2001).
Lovett-Racke et al., Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease,Journal of Immunology, 172:5790-5798 (2004).
Malhotra et al., Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis,Expert Opinions in Pharmacotherapy, 6(9):1455-1461 (2005).
Morgensen et al., Design and Synthesis of Novel PPARα/γ/δ Triple Activators Using a Known PPARα/γ Dual Activator as Structural Template,Bioorg.&Med. Chem. Lett., 13:257-260 (2002).
Miyaura, N. and Suzuki, A., Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds,Chem. Rev. 95:2457 (1995).
Oliver et al., A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport,Proc. Natl. Acad. Sci., 98:5306-5311 (2001).
Patel et al., Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy,Journal of Immunology, 2003, 170:2663-2669.
Sastre et al., Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precurser Protein through Regulation of β-Secretase,Journal of Neuroscience, 23(30):9796 (2003).
Sauerberg et al., Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPAR α/γ Agonists with Hypolipidemic and Antidiabetic Activity,J. Med. Chem. 45:789-804 (2002).
Storer et al., Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: Implications for multiple sclerosis,Journal of Neuroimmunology, 161:113-122 (2005).
Yousef, J. and Badr, M., Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control,Journal of Biomedicine and Biotechnology, (3):156-166 (2004).
U.S. Appl. No. 11/289,751, filed Nov. 29, 2005.
U.S. Appl. No. 11/517,010, filed Sep. 6, 2006.
U.S. Appl. No. 11/517,573, filed Sep. 6, 2006.
U.S. Appl. No. 11/679,792, filed Feb. 27, 2007.
U.S. Appl. No. 11/679,738, filed Feb. 27, 2007.
U.S. Appl. No. 11/679,777, filed Feb. 27, 2007.
Acton et al., Benzoyl 2-methyl indoles as selective PPARγ modulators. Bioorganic & Medicinal Chemistry Letters, 15(2):357-362, 2005.
Aldred, et al., “Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas,” Oncogene 22:3412-3416 (2003).
Alfthan, Surface Plasmon Resonance Biosensors as a Tool in Antibody Engineer

Affiliated with

Also associated with

Rating

PPAR active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PPAR active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PPAR active compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289014